Supratentorial meningioma

Clinical trials for Supratentorial meningioma explained in plain language.

Never miss a new study

Get alerted when new Supratentorial meningioma trials appear

Sign up with your email to follow new studies for Supratentorial meningioma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

A phase 2, single arm, multi-center, open label trial combining optune with concurrent bevacizumab in the setting of recurrent or progressive meningioma

Completed

The purpose of this research study is to determine the effects bevacizumab (the study drug) combined with Optune (the study device) tumor treatment field therapy has on meningiomas. Bevacizumab is considered investigational because the US Food and Drug Administration (FDA) has no…

Matched conditions: SUPRATENTORIAL MENINGIOMA

Phase 2 • Sponsor: Northwestern University

Last updated Sep 09, 2026 16:00 UTC

Supratentorial meningioma

Get alerted when new Supratentorial meningioma trials appear

A phase 2, single arm, multi-center, open label trial combining optune with concurrent bevacizumab in the setting of recurrent or progressive meningioma